Critic Reviews

With its focus on intimate detail, Off Label is not a conventional "issue film" reaching for conclusions. Palmieri and Mosher have taken on a huge and urgent topic, and their work's impact rests on their refusal to tell viewers how to feel.

Don't discount October Country filmmakers Michael Palmieri and Donal Mosher's tragicomically beautiful art-doc, which sensitively favors unflinching testimonials and visually impressionistic observations over journalistic activism.

Sincerely angry about the crisis in polypharmacy, this narrative suffers from a documentarian form of A.D.D.

Though it lacks the specific argumentative point of view that might have carried it into the mainstream, its sympathetic approach to subjects offers a compelling human perspective on questions that get too little attention in debates about health care.

Hypocrisy aside, Off Label’s biggest problem is that, for a movie that features a lot of people talking about a lot of things, it doesn’t have a lot to say; its scatterbrained, switching-between-browser-tabs structure guarantees that no idea gets developed very far.

The film’s stacked stories naggingly lack a cohesive train of thought beyond the often harmful pervasiveness of pharmaceuticals in American society.

Each scene in Off Label, viewed in isolation, seems perfectly fine, even fairly interesting. It’s how all of those scenes fit together—or, rather, how they absolutely don’t—that creates the overall sense of grotesque deformity.